Most Ozempic, Wegovy Claims Survive MDL Dismissal Bid

By Matthew Santoni · August 18, 2025, 5:32 PM EDT

Eli Lilly & Co. and Novo Nordisk will have to face most of a multidistrict litigation accusing them of misleading consumers over the risks and benefits of popular weight loss drugs...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login